1. Home
  2. Browse
  3. Neurodegeneration

29 open

Neurodegeneration funding

29 open opportunities tagged Neurodegeneration, across federal agencies and private foundations. Sorted by deadline.

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

PAR-25-226National Institutes of Health3 review criteria on fileagency framework

—

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

PAR-27-057National Institutes of Health3 review criteria on fileagency framework

$500k

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

PAR-25-297National Institutes of Health5 review criteria on file

$1.5M

DoW Parkinson’s, Investigator-Initiated Research Award

HT942526PRPIIRADefense Health Agency Contracting Activity - DHACAReview criteria on file

—

DoW Parkinson’s, Early Investigator Research Award

HT942526PRPEIRADefense Health Agency Contracting Activity - DHACAReview criteria on file

—

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

RFA-DA-27-004National Institutes of Health3 review criteria on file

—

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

PAR-25-374National Institutes of Health3 review criteria on fileagency framework

$1M

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

RFA-AG-27-010National Institutes of Health

—

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

RFA-NS-26-001National Institutes of Health3 review criteria on file

—

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

PAR-24-321National Institutes of Health8 review criteria on file

—

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

PAR-25-248National Institutes of Health3 review criteria on file

—

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

RFA-AG-26-011National Institutes of Health8 review criteria on file

$200k

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

RFA-AG-26-010National Institutes of Health9 review criteria on file

$400k

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

RFA-OD-27-005National Institutes of Health3 review criteria on fileagency framework

—

INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)

RFA-OD-27-003National Institutes of Health3 review criteria on fileagency framework

$200k

INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)

RFA-OD-27-004National Institutes of Health3 review criteria on fileagency framework

$500k

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)

RFA-DC-27-003National Institutes of Health3 review criteria on file

$500k

BrightFocus Foundation — Hidden RNA Alterations by Jumping Genes in Alzheimer's Disease

BrightFocus Foundation

$25k
Rolling

BrightFocus Foundation — Hidden RNA Alterations by Jumping Genes in Alzheimer's Disease

BrightFocus Foundation

$25k
Rolling

BrightFocus Foundation — Spatial Responses to Elevated Pressure in the Human Optic Nerve Head

BrightFocus Foundation

$150k
Rolling

BrightFocus Foundation — Artificial Intelligence-Guided Drug Discovery for Alzheimer's Disease

BrightFocus Foundation

$25k
Rolling

BrightFocus Foundation — Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening

BrightFocus Foundation

$150k
Rolling

BrightFocus Foundation — Activating the Eye’s Own Nitric Oxide to Fight Glaucoma

BrightFocus Foundation

$150k
Rolling

BrightFocus Foundation — Artificial Intelligence-Guided Drug Discovery for Alzheimer's Disease

BrightFocus Foundation

$25k
Rolling

BrightFocus Foundation — Spatial Responses to Elevated Pressure in the Human Optic Nerve Head

BrightFocus Foundation

$150k
Rolling

Alzheimer's Association — The International Research Grant Program Council

Alzheimer's Association

—
Rolling

BrightFocus Foundation — Understanding Natural Protection Against Cognitive Decline: The 100-plus Study

BrightFocus Foundation

$100k
Rolling

BrightFocus Foundation — Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening

BrightFocus Foundation

$150k
Rolling

BrightFocus Foundation — The Immune Landscape of the Human Optic Nerve Head

BrightFocus Foundation

$150k
Rolling

Read the review criteria before you apply

A free account shows the review criteria on file and the announcement text where we hold it. The eligibility check, funded precedents and the Reviewer Scorecard are on Plus, $39 a month. No card required.

Create free accountBrowse all funders

Related subjects